American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
Top Sells
| 1 |
PayPal
PYPL
|
+$363M |
| 2 |
Visa
V
|
+$340M |
| 3 |
Starbucks
SBUX
|
+$222M |
| 4 |
Chubb
CB
|
+$221M |
| 5 |
Danaher
DHR
|
+$197M |
Sector Composition
| 1 | Technology | 22.9% |
| 2 | Financials | 13.74% |
| 3 | Healthcare | 13.7% |
| 4 | Consumer Discretionary | 13.19% |
| 5 | Industrials | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Yelp
YELP
$1.99B
| $877K | ﹤0.01% |
24,204
| – | – |
|
|
GTM
1702
ZoomInfo Technologies
GTM
$3.89B
| $871K | ﹤0.01% |
+13,573
| New | +$871K |
|
|
ONC
1703
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.6B
| $868K | ﹤0.01% |
3,204
| – | – |
|
1704
Fiserv
FI
$72.1B
| $867K | ﹤0.01% |
8,357
+1,079
| +15% | +$112K |
|
1705
Dentsply Sirona
XRAY
$2.7B
| $867K | ﹤0.01% |
15,539
-320
| -2% | -$17.9K |
|
1706
Credicorp
BAP
$21.1B
| $866K | ﹤0.01% |
7,091
+1,385
| +24% | +$169K |
|
1707
Vanda Pharmaceuticals
VNDA
$259M
| $865K | ﹤0.01% |
55,104
| – | – |
|
1708
Village Super Market
VLGEA
$586M
| $864K | ﹤0.01% |
36,927
+9,443
| +34% | +$221K |
|
1709
Assurant
AIZ
$10.5B
| $863K | ﹤0.01% |
5,541
+809
| +17% | +$126K |
|
1710
Grupo Aeroportuario del Pacifico
PAC
$12.7B
| $863K | ﹤0.01% |
6,276
+3,541
| +129% | +$487K |
|
1711
Ingersoll Rand
IR
$31.4B
| $862K | ﹤0.01% |
13,926
+2,792
| +25% | +$173K |
|
1712
Arrowhead Research
ARWR
$3.96B
| $861K | ﹤0.01% |
12,986
+1,474
| +13% | +$97.7K |
|
1713
RB Global
RBA
$21.7B
| $859K | ﹤0.01% |
14,042
+9,807
| +232% | +$600K |
|
1714
Progress Software
PRGS
$1.79B
| $858K | ﹤0.01% |
17,770
| – | – |
|
1715
Amalgamated Financial
AMAL
$849M
| $857K | ﹤0.01% |
51,102
+13,306
| +35% | +$223K |
|
1716
ITT
ITT
$14B
| $856K | ﹤0.01% |
8,375
+404
| +5% | +$41.3K |
|
1717
PetMed Express
PETS
$58M
| $856K | ﹤0.01% |
33,892
+19,810
| +141% | +$500K |
|
1718
StoneX
SNEX
$4.94B
| $856K | ﹤0.01% |
31,433
+4,282
| +16% | +$117K |
|
1719
W.R. Berkley
WRB
$27.6B
| $856K | ﹤0.01% |
23,384
-7,169
| -23% | -$262K |
|
1720
Bio-Rad Laboratories Class A
BIO
$7.58B
| $852K | ﹤0.01% |
1,128
+289
| +34% | +$218K |
|
1721
Rapid7
RPD
$1.26B
| $852K | ﹤0.01% |
7,240
+161
| +2% | +$18.9K |
|
1722
C.H. Robinson
CHRW
$15.7B
| $850K | ﹤0.01% |
7,902
+785
| +11% | +$84.4K |
|
1723
Alaska Air
ALK
$6.82B
| $847K | ﹤0.01% |
16,249
-232,670
| -93% | -$12.1M |
|
1724
Sensient Technologies
SXT
$4.37B
| $847K | ﹤0.01% |
8,463
-1,267
| -13% | -$127K |
|
1725
Takeda Pharmaceutical
TAK
$47.6B
| $843K | ﹤0.01% |
61,839
+4,945
| +9% | +$67.4K |
|